Dr. Reddy's Laboratories
RDY
#1699
Rank
HK$92.39 B
Marketcap
HK$110.46
Share price
0.35%
Change (1 day)
-1.28%
Change (1 year)

Dr. Reddy's Laboratories (RDY) - Cash on Hand

Cash on Hand as of September 2025 : HK$6.11 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company has HK$6.11 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Dr. Reddy's Laboratories - Cash on Hand chart (from 2001 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-03-31HK$5.27 B-31.08%
2024-03-31HK$7.64 B29.52%
2023-03-31HK$5.90 B28.97%
2022-03-31HK$4.57 B24.69%
2021-03-31HK$3.67 B38.61%
2020-03-31HK$2.64 B-5.36%
2019-03-31HK$2.79 B10.73%
2018-03-31HK$2.52 B16.33%
2017-03-31HK$2.17 B-53.55%
2016-03-31HK$4.67 B-5.19%
2015-03-31HK$4.93 B13.8%
2014-03-31HK$4.33 B37.18%
2013-03-31HK$3.16 B14.02%
2012-03-31HK$2.77 B174.92%
2011-03-31HK$1.00 B-43.14%
2010-03-31HK$1.77 B88.79%
2009-03-31HK$0.93 B-60.26%
2008-03-31HK$2.36 B-27.59%
2007-03-31HK$3.26 B402.68%
2006-03-31HK$0.64 B-62.26%
2005-03-31HK$1.72 B38.36%
2004-03-31HK$1.24 B4.55%
2003-03-31HK$1.18 B45.85%
2002-03-31HK$0.81 B922%
2001-03-31HK$79.79 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
HK$116.64 B 1,806.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$17.14 B 180.35%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
HK$34.59 B 465.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
HK$75.92 B 1,141.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
HK$81.36 B 1,230.10%๐Ÿ‡ซ๐Ÿ‡ท France